Showing results (241-250 of 349) with videos related to

Sort By:
Pageof 35
Journal for Immunotherapy of Cancer|October 24, 2024
Alum-anchored IL-12 combined with cytotoxic chemotherapy and immune checkpoint blockade enhanced antitumor immune responses in head and neck cancer modelsKellsye P Fabian, Ginette Santiago-Sanchez, Michelle R Padget, et al.
Oral Oncology|July 10, 2017
Dose-dependent enhancement of T-lymphocyte priming and CTL lysis following ionizing radiation in an engineered model of oral cancerMegan Morisada, Ellen C Moore, Rachel Hodge, et al.
Vaccine|December 25, 2007
Recombinant Saccharomyces cerevisiae (yeast-CEA) as a potent activator of murine dendritic cellsMichael B Bernstein, Mala Chakraborty, Elizabeth K Wansley, et al.
Cancer Immunology, Immunotherapy : CII|February 8, 2008
Use of radiolabeled monoclonal antibody to enhance vaccine-mediated antitumor effectsMala Chakraborty, Alexander Gelbard, Jorge A Carrasquillo, et al.
Retrovirology|May 17, 2011
A functional role for ADAM10 in human immunodeficiency virus type-1 replicationBrian M Friedrich, James L Murray, Guangyu Li, et al.
Journal for Immunotherapy of Cancer|June 22, 2018
Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapiesJay Friedman, Megan Morisada, Lillian Sun, et al.
Plos One|July 30, 2013
Combination therapy with local radiofrequency ablation and systemic vaccine enhances antitumor immunity and mediates local and distal tumor regressionSofia R Gameiro, Jack P Higgins, Matthew R Dreher, et al.
Psychopharmacology|November 18, 2005
The mGluR5 antagonist MPEP selectively inhibits the onset and maintenance of ethanol self-administration in C57BL/6J miceClyde W Hodge, Michael F Miles, Amanda C Sharko, et al.
The British Journal of Ophthalmology|January 24, 2008
Clinical features distinguishing angle closure from pseudoplateau versus plateau irisS Shukla, K F Damji, P Harasymowycz, et al.
Cancer Immunology Research|December 23, 2020
Therapy of Established Tumors with Rationally Designed Multiple Agents Targeting Diverse Immune-Tumor Interactions: Engage, Expand, EnableKellsye P Fabian, Anthony S Malamas, Michelle R Padget, et al.
Pageof 35